Preclinical safety of human embryonic stem cell-derived oligodendrocyte progenitors supporting clinical trials in spinal cord injury.
Saved in:
| Title: | Preclinical safety of human embryonic stem cell-derived oligodendrocyte progenitors supporting clinical trials in spinal cord injury. |
|---|---|
| Authors: | Priest CA; Geron Corporation, 149 Commonwealth St., Menlo Park, CA 94025, USA.; California Institute of Regenerative Medicine, 210 King St., San Francisco, CA 94107, USA., Manley NC; Asterias Biotherapeutics Inc., 230 Constitution Drive, Menlo Park, CA 94025, USA., Denham J; Geron Corporation, 149 Commonwealth St., Menlo Park, CA 94025, USA.; Dark Horse Consulting, 1999 South Bascom Ave Suite 700, Campbell, CA 95008, USA., Wirth ED 3rd; Geron Corporation, 149 Commonwealth St., Menlo Park, CA 94025, USA.; Asterias Biotherapeutics Inc., 230 Constitution Drive, Menlo Park, CA 94025, USA., Lebkowski JS; Geron Corporation, 149 Commonwealth St., Menlo Park, CA 94025, USA.; Asterias Biotherapeutics Inc., 230 Constitution Drive, Menlo Park, CA 94025, USA. |
| Source: | Regenerative medicine [Regen Med] 2015 Nov; Vol. 10 (8), pp. 939-58. Date of Electronic Publication: 2015 Sep 08. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 101278116 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1746-076X (Electronic) Linking ISSN: 17460751 NLM ISO Abbreviation: Regen Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1746-076X |
|---|---|
| DOI: | 10.2217/rme.15.57 |
